Helius Medical Technologies Inc. (NASDAQ:HSDT) went down by -5.62% from its latest closing price compared to the recent 1-year high of $15.05. The company’s stock price has collected -11.76% of loss in the last five trading sessions.
Is It Worth Investing in Helius Medical Technologies Inc. (NASDAQ :HSDT) Right Now?
Plus, the 36-month beta value for HSDT is at 0.78. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Helius Medical Technologies Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $4.25, which is $3.76 above the current price. HSDT currently public float of 26.87M and currently shorts hold a 3.11% ratio of that float. Today, the average trading volume of HSDT was 4.43M shares.
HSDT’s Market Performance
HSDT stocks went down by -11.76% for the week, with a monthly drop of -1.29% and a quarterly performance of -68.18%, while its annual performance rate touched -96.66%. The volatility ratio for the week stands at 6.82% while the volatility levels for the past 30 days are set at 10.44% for Helius Medical Technologies Inc. The simple moving average for the period of the last 20 days is -11.91% for HSDT stocks with a simple moving average of -82.29% for the last 200 days.
Analysts’ Opinion of HSDT
Many brokerage firms have already submitted their reports for HSDT stocks, with Noble Capital Markets repeating the rating for HSDT by listing it as a “Outperform.” The predicted price for HSDT in the upcoming period, according to Noble Capital Markets is $20 based on the research report published on March 24th of the previous year 2021.
HSDT Trading at -35.83% from the 50-Day Moving Average
After a stumble in the market that brought HSDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -96.74% of loss for the given period.
Volatility was left at 10.44%, however, over the last 30 days, the volatility rate increased by 6.82%, as shares sank -4.80% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -64.75% lower at present.
During the last 5 trading sessions, HSDT fell by -11.76%, which changed the moving average for the period of 200-days by -91.54% in comparison to the 20-day moving average, which settled at $0.5550. In addition, Helius Medical Technologies Inc. saw -90.56% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at HSDT starting from ANDREEFF DANE, who purchase 150,000 shares at the price of $0.53 back on Sep 13. After this action, ANDREEFF DANE now owns 238,618 shares of Helius Medical Technologies Inc., valued at $80,205 using the latest closing price.
ANDREEFF DANE, the President and CEO of Helius Medical Technologies Inc., purchase 8,868 shares at $0.54 during a trade that took place back on Sep 12, which means that ANDREEFF DANE is holding 144,819 shares at $4,828 based on the most recent closing price.
Stock Fundamentals for HSDT
Current profitability levels for the company are sitting at:
- -3472.03 for the present operating margin
- +4.60 for the gross margin
The net margin for Helius Medical Technologies Inc. stands at -3473.56. Equity return is now at value -228.10, with -171.40 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 4.75.